CLDI.WS
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
CLDI.WS
Delisted
CLDI.WS was delisted on the 17th of October, 2024.
27 hedge funds and large institutions have $6.17M invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
27
Holding in Top 10
–
Calls
$4.88M
Puts
–
Top Buyers
| 1 | +$196K | |
| 2 | +$180K | |
| 3 | +$179K | |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$165K |
| 5 |
ICM
Ionic Capital Management
New York
|
+$85K |
Top Sellers
| 1 | -$315K | |
| 2 | -$254K | |
| 3 | -$50.3K | |
| 4 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
-$50K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$10.6K |